Trending News
News
News
New Stem Cell-Based Model Mimics Mechanisms of Alzheimer's Disease
A novel cell model for studying the impact of the immune system on neuronal repair processes in Alzheimer’s disease
News
Biogazelle Appoints Armin Winands as New CEO
Biogazelle is pleased to announce the appointment of Armin Winands as its new
CEO effective 1st July 2018, following Jan Hellemans who will take on the role of CTO after 10 years as CEO.
CEO effective 1st July 2018, following Jan Hellemans who will take on the role of CTO after 10 years as CEO.
News
Killer Immune Cells that Halt Malaria Could Hold Key to New Vaccines
Scientists have revealed that immune cells called natural killer (NK) cells may play a key role in ridding the body of malaria-infected blood cells.
News
BioAscent Secures Investment to Expand its Integrated Drug Discovery Services
£1.6m investment recognises BioAscent’s unique capabilities.
News
Advanced Breast Cancer: Triple Therapy Could Boost Treatment & Prevent Relapse
Treating advanced breast cancer with three drugs instead of one could boost the effectiveness of treatment and stop tumours developing resistance, a new study reports.
News
Stem Cells Restore Function in Primate Heart-failure Study
Researchers have successfully used human stem cells to restore heart function in monkeys with heart failure. The findings suggest that the technique will be effective in patients with heart failure, the leading cause of death in the world.
News
Virus That Might Actually Boost Our Immune System
Lifelong cytomegalovirus infection may be beneficial, boosting the immune system in old age, when we need it most, according to a recent study.
News
Improvements Still Possible for Antibiotic Use
Two research reports have looked at the use of antibiotics and antibiotic resistance in the Netherlands, among humans and animals. To allow antibiotics to continue to be used in the future, we must keep working on tackling antibiotic resistance.
News
A New Player Enters the CAR-T Immunotherapy Arena
Emerging CAR-T immunotherapies leverage modified versions of patient’s T-cells to target and kill cancer cells. In a new study researchers report that similarly modified natural killer cells derived from human induced pluripotent stem cells also displayed heightened activity against a mouse model of ovarian cancer.
News
Unlocking Secrets Behind Cancer Drug Resistance
New research provides insights into an underlying mechanism that could explain why new cancer therapies to help treat metastatic melanoma do not always work on patients, paving the way for predicting which patients will benefit from certain drugs.
Advertisement